These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 22799337
1. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology. Sui XL, Wang H, Sun XW. Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337 [Abstract] [Full Text] [Related]
2. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors. Kang GH, Srivastava A, Kim YE, Park HJ, Park CK, Sohn TS, Kim S, Kang DY, Kim KM. Mod Pathol; 2011 Jun; 24(6):866-75. PubMed ID: 21358619 [Abstract] [Full Text] [Related]
3. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1. Baskin Y, Kocal GC, Kucukzeybek BB, Akbarpour M, Kayacik N, Sagol O, Ellidokuz H, Oztop I. Oncol Res; 2016 Jun; 24(1):41-53. PubMed ID: 27178821 [Abstract] [Full Text] [Related]
4. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers? Ríos-Moreno MJ, Jaramillo S, Pereira Gallardo S, Vallejo A, Mora M, García-Escudero A, Amérigo J, González-Cámpora R. Pathol Res Pract; 2012 Feb 15; 208(2):74-81. PubMed ID: 22197035 [Abstract] [Full Text] [Related]
5. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Miettinen M, Wang ZF, Lasota J. Am J Surg Pathol; 2009 Sep 15; 33(9):1401-8. PubMed ID: 19606013 [Abstract] [Full Text] [Related]
6. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours. Wang C, Jin MS, Zou YB, Gao JN, Li XB, Peng F, Wang HY, Wu ZD, Wang YP, Duan XM. Scand J Gastroenterol; 2013 Sep 15; 48(9):1055-65. PubMed ID: 23862765 [Abstract] [Full Text] [Related]
7. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors. Dailey DD, Ehrhart EJ, Duval DL, Bass T, Powers BE. J Vet Diagn Invest; 2015 May 15; 27(3):268-77. PubMed ID: 25862711 [Abstract] [Full Text] [Related]
8. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Liegl B, Hornick JL, Corless CL, Fletcher CD. Am J Surg Pathol; 2009 Mar 15; 33(3):437-46. PubMed ID: 19011564 [Abstract] [Full Text] [Related]
9. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations. Rizzo FM, Palmirotta R, Marzullo A, Resta N, Cives M, Tucci M, Silvestris F. BMC Cancer; 2016 Feb 11; 16():87. PubMed ID: 26867653 [Abstract] [Full Text] [Related]
10. [Clinicopathologic features and immunophenotypes of CD117-negative gastrointestinal stromal tumor]. Shi JL, Chang XY, Chen J. Zhonghua Bing Li Xue Za Zhi; 2011 May 11; 40(5):310-4. PubMed ID: 21756824 [Abstract] [Full Text] [Related]
11. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M. Am J Pathol; 2004 Jul 11; 165(1):107-13. PubMed ID: 15215166 [Abstract] [Full Text] [Related]
12. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)]. He HY, Fang WG, Zhong HH, Li Y, Zheng J, Du J, Heng WJ, Wu BQ. Zhonghua Bing Li Xue Za Zhi; 2006 May 11; 35(5):262-6. PubMed ID: 16776995 [Abstract] [Full Text] [Related]
13. Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs). Miwa S, Nakajima T, Murai Y, Takano Y, Sugiyama T. J Gastroenterol; 2008 May 11; 43(7):531-7. PubMed ID: 18648740 [Abstract] [Full Text] [Related]
14. Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors. Sahu KK, Tapadia R, Kini JR, Pai RR, Kini H, Nirupama M, Pooja KS. J Cancer Res Ther; 2019 May 11; 15(1):138-141. PubMed ID: 30880769 [Abstract] [Full Text] [Related]
15. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors. Kara T, Serinsoz E, Arpaci RB, Gubur O, Orekici G, Ata A, Colak T, Arican A. Pathol Res Pract; 2013 Jul 11; 209(7):413-7. PubMed ID: 23722018 [Abstract] [Full Text] [Related]
16. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors. Jang BG, Lee HE, Kim WH. Virchows Arch; 2015 Oct 11; 467(4):393-403. PubMed ID: 26243012 [Abstract] [Full Text] [Related]
18. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors. Şahin S, Ekinci Ö, Seçkin S, Dursun A. Turk Patoloji Derg; 2017 Oct 11; 33(1):1-8. PubMed ID: 28044310 [Abstract] [Full Text] [Related]
19. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses. Peterson MR, Piao Z, Weidner N, Yi ES. Appl Immunohistochem Mol Morphol; 2006 Dec 11; 14(4):390-6. PubMed ID: 17122634 [Abstract] [Full Text] [Related]
20. Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour. Parfitt JR, Rodriguez-Justo M, Feakins R, Novelli MR. Histopathology; 2008 Jun 11; 52(7):816-23. PubMed ID: 18494611 [Abstract] [Full Text] [Related] Page: [Next] [New Search]